StockNews.AI • 2 days
BOSTON, Jan. 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, February 5, 2026. The
Original sourceHaemonetics Corporation plans to publish its third quarter fiscal results on February 5, 2026, accompanied by a conference call for investors. This financial update is critical for stakeholders and could influence the stock's trajectory significantly.
Investors should closely monitor HAE's Q3 results for potential trading opportunities.
This update falls under earnings reporting, a crucial factor for evaluating company performance and stock price movements. Investors often closely watch earnings calls for insights into future guidance and strategic direction.
Positive earnings surprises often result in stock price increases, as seen historically. If Haemonetics meets or exceeds expectations, it could bolster investor confidence.
The article provides important information about Haemonetics’ financial results, which can directly influence the stock price leading to heightened investor interest.
The immediate effects of earnings releases typically drive short-term stock volatility. Historical data indicates price movements often occur during earnings season.
BOSTON, Jan. 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, February 5, 2026. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 5, 2026.
The call can be accessed via teleconference at: Q3 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/uz42wd2z
A replay of the conference call and webcast will be available for one year beginning on February 5, 2026 at 11:00 am ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2026-results-february-5-2026-302655773.html
SOURCE Haemonetics Corporation